Document is current
Any future updates will be listed below
-
Authors
Tashiro, Yu https://orcid.org/0000-0002-4417-8009
Akamatsu, Shusuke
Ueno, Kentaro
Kamoto, Toshiyuki
Terada, Naoki
Hida, Takuya
Kurahashi, Ryoma
Kamba, Tomomi
Saito, Atsushi
Lee, Takumi
Morita, Satoshi
Kobayashi, Takashi
-
Funding
Funding for this research was provided by:
Astellas Pharma Inc.
- License Information
-
More Information
Article History
Received: 3 March 2024
Accepted: 30 July 2024
First Online: 17 August 2024
Declarations
:
: Yu Tashiro, Kentaro Ueno, Naoki Terada, Takuya Hida, and Ryoma Kurahashi have no conflict of interest. Shusuke Akamatsu has received honoraria and research funding from Astellas Pharma Inc. Toshiyuki Kamoto has received honoraria from Janssen Pharmaceuticals, AstraZeneca, Sanofi, and Takeda; received research funding from EP CRSU Company Limited, MSD, Bayer Yakuhin Limited, and AstraZeneca; and scholarship funding from Takeda and Shin Nippon Biomedical Laboratories. Tomomi Kamba has received honoraria from Takeda, AstraZeneca, and Merck Biopharma. Atsushi Saito and Takumi Lee are employees of Astellas Pharma Inc. Satoshi Morita has received honoraria from AstraZeneca, Astellas Pharma Inc, Bristol Myers Squibb, Chugai, Eisai, Elli Lily, MSD, and Ono. Takashi Kobayashi has received honoraria from Astellas Pharma Inc, Janssen, and Bayer.
